Analysis unavailable for this viewpoint.

• The WHO's approval of the mpox vaccine for children is a significant step to combat the rising cases of the disease, especially in vulnerable populations like children.
• Experts highlight that children are at a higher risk of severe outcomes from mpox, which underscores the importance of vaccinating this demographic.
• The vaccine authorization by WHO reflects a proactive approach to address public health concerns in Africa, particularly in countries like Congo where outbreaks are pronounced.